1.0Cloudbreak Pharma, Inc.https://cloudbreakpharma.com/zh_hkastraelemhttps://cloudbreakpharma.com/zh_hk/author/astraelem/rich600338<blockquote class="wp-embedded-content" data-secret="L6CEcIcXHC"><a href="https://cloudbreakpharma.com/zh_hk/about/scott-whitcup/">Scott Whitcup</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://cloudbreakpharma.com/zh_hk/about/scott-whitcup/embed/#?secret=L6CEcIcXHC" width="600" height="338" title="Scott Whitcup — Cloudbreak Pharma, Inc." data-secret="L6CEcIcXHC" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://cloudbreakpharma.com/wp-includes/js/wp-embed.min.js </script>Scott Whitcup, MD Scientific Advisory Board Dr. Scott Whitcup is the Founder and CEO of Akrivista and Whitecap Biosciences, two companies focused on developing new therapies in ophthalmology and dermatology. Previously, Dr. Whitcup was the Executive Vice President, Research and Development and Chief Scientific Officer at Allergan where he lead an organization focused on therapeutic […]https://cloudbreakpharma.com/wp-content/uploads/2019/09/Scott-Whitcup.jpg200200